Gangnam Severance Hospital
| Republic of Korea | Thailand | Turkey | |
| NanoKnife | from AUD $24,404 | from AUD $15,340 | from AUD $13,248 |
| CyberKnife | from AUD $16,037 | from AUD $41,836 | from AUD $6,624 |
| Enucleation of tumor on pancreas | - | - | from AUD $10,459 |
| Actinium-225 Therapy | - | from AUD $34,863 | from AUD $32,011 |
No hidden fees – just official clinic prices. Pay at the clinic for Pancreatic neuroendocrine tumors treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Pancreatic neuroendocrine tumors treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Pancreatic neuroendocrine tumors treatment journey.
Surgical resection is the primary treatment for localised pancreatic neuroendocrine tumours in South Korea. Specialist surgeons use techniques such as enucleation or the Whipple procedure to remove tumours. Advanced cases may involve systemic therapies. These include somatostatin analogues, targeted drugs, and peptide receptor radionuclide therapy.
Bookimed Expert Insight: Many centres offer general oncology. However, Korea University Anam Hospital provides same-day consultations for new cancer patients. This speed is a significant advantage for Australians seeking rapid staging of neuroendocrine tumours. Their expertise in bloodless surgery options also caters to complex cases. In these cases, traditional resection carries higher risks.
Patient Consensus: Patients in the Republic of Korea find that surgery remains the main curative path. It is the main treatment for localised tumours. Many note that recurring cases often benefit from peptide receptor radionuclide therapy. It is typically combined with monthly octreotide injections.
South Korea offers Peptide Receptor Radionuclide Therapy (PRRT) for advanced pancreatic neuroendocrine tumours. Leading Seoul hospitals provide 177Lu-DOTATATE treatments for somatostatin receptor-positive tumours. Expert consensus in Korea supports PRRT as a standard option for metastatic cases with high survival rates.
Bookimed Expert Insight: Korea University Anam Hospital provides same-day consultations and admission for new cancer patients. This speed is vital for international patients starting PRRT. Most Seoul centres, including Gangnam Severance, offer free interpreters. This helps Australians navigate the complex radiation safety protocols required after treatment.
Patient Consensus: Patients note PRRT requires strict radiation precautions at home, such as sleeping alone for several days. They emphasise finding neuroendocrine specialists as general oncologists may be less familiar with radionuclide protocols in South Korea.
South Korean university hospitals are world leaders in treating functional pancreatic neuroendocrine tumours. Major Seoul centres perform thousands of oncology operations annually. They use robotic surgery and therapies like CyberKnife to manage hormone-producing tumours such as insulinomas. Most facilities hold JCI accreditation.
Bookimed Expert Insight: South Korea's advantage lies in its extreme surgical volume and early adoption of robotic systems. Gangnam Severance Hospital was Asia's first to use the da Vinci system for minimally invasive work. With long-term experience, their surgical teams handle postoperative complications more effectively than lower-volume centres. Patients with rare functional tumours benefit from this refined technical expertise.
Patient Consensus: Patients note that major Seoul university hospitals provide fantastic care for serious cancers. They recommend choosing a high-volume specialist centre in South Korea. This means the surgical team has extensive experience with neuroendocrine cases.
South Korea provides pancreatic neuroendocrine tumour (pNET) care through JCI-accredited high-volume centres. Patients access specialised therapies like Peptide Receptor Radionuclide Therapy (PRRT) and robotic surgery. Multidisciplinary teams manage complex cases. These centres offer rapid coordination with same-day consultations and tests.
Bookimed Expert Insight: South Korean clinics specialise in conversion surgery for previously unresectable tumours. Gangnam Severance Hospital was first in Asia to use robotic systems for such complex cases. This approach allows surgeons to remove tumours that other hospitals might consider inoperable.
Patient Consensus: Patients in the Republic of Korea report significant quality-of-life gains. These include improved energy and relief from diarrhoea. They emphasise that halting tumour growth is a successful outcome even without immediate shrinkage.